Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial

Documenti analoghi

• Comparison of Helicobacter pylori eradication rates between 7 and 14 days of tailored therapy according to clarithromycin resistance test: A randomized, multicenter, non‐inferiority study
  di: Kyoungwon Jung, et al.
  Pubblicazione: (2024)
• Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta‐Analysis
  di: Sun Jae Moon, et al.
  Pubblicazione: (2025)
• Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance: A Prospective, Randomized, Single Tertiary Center Study
  di: Jung Won Lee, et al.
  Pubblicazione: (2024)
• Helicobacter pylori Eradication Is Associated With a Reduced Risk of Metachronous Gastric Neoplasia by Restoring Immune Function in the Gastric Mucosa
  di: Min‐Jae Kim, et al.
  Pubblicazione: (2025)
• Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐ CREATE Study
  di: Joon Sung Kim, et al.
  Pubblicazione: (2024)